Apple and Masimo are back in a California court this week for a bench trial that will see Masimo arguing that Apple illegally ...

Masimo Corporation MASI is well-poised for growth ... reflecting a decline of 12.5% on a reported basis and 10.8% at CER year over year. Rising operating costs led to the contraction of the ...

Observing a 5.55% increase, the current average has risen from the previous average price target of $163.67. The analysis of recent analyst actions sheds light on the perception of Masimo by ...

--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release third quarter 2024 financial results for the period ended September 28, 2024, after the market closes on Tuesday, November 5, 2024. The ...

The consensus rating for Masimo is Buy, based on 2 analyst ratings. With an average one-year price target of $167.5, there's a potential 16.14% upside. Analyzing Ratings Among Peers The below ...

Masimo Names Interim CEO As Activist Board Members ... This compares to the stock's 8.5% loss over the past four weeks.

Apple won the case, though was only awarded a nominal $250, which is the smallest amount it was possible for the court to order. In other words, yes Masimo did in infringe Apple’s patents, but there ...

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its ...